These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 3021932)

  • 41. Prognostic value of complete response after the initial treatment for malignant astrocytoma.
    Kayama T; Kumabe T; Tominaga T; Yoshimoto T
    Neurol Res; 1996 Aug; 18(4):321-4. PubMed ID: 8875449
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Linear contrast enhancement at the operative site on early post-operative CT after removal of brain tumors.
    Nicoletti GF; Barone F; Passanisi M; Mancuso P; Albanese V
    J Neurosurg Sci; 1994 Jun; 38(2):131-5. PubMed ID: 7891195
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment and survival of low-grade astrocytoma in adults--1977-1988.
    McCormack BM; Miller DC; Budzilovich GN; Voorhees GJ; Ransohoff J
    Neurosurgery; 1992 Oct; 31(4):636-42; discussion 642. PubMed ID: 1407448
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Individualized therapy and outcomes of microsurgery, radiotherapy, and chemotherapy for astrocytoma].
    Zhou WN; Chen ZP; You C; Mu YG; Sai K; Zhang JY; Zhang XH; Cheng JJ; Xu HC
    Ai Zheng; 2004 Nov; 23(11 Suppl):1555-60. PubMed ID: 15566679
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Combination chemotherapy using carboplatin (JM-8) and etoposide (JET therapy) for recurrent malignant gliomas: a phase II study.
    Watanabe K; Kanaya H; Fujiyama Y; Kim P
    Acta Neurochir (Wien); 2002 Dec; 144(12):1265-70; discussion 1270. PubMed ID: 12478337
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prognostic significance of lesion size for glioblastoma multiforme.
    Reeves GI; Marks JE
    Radiology; 1979 Aug; 132(2):469-71. PubMed ID: 223197
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Radiotherapy in supratentorial gliomas. A study of 821 cases.
    Heesters M; Molenaar W; Go GK
    Strahlenther Onkol; 2003 Sep; 179(9):606-14. PubMed ID: 14628126
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Imaging-based stereotaxic serial biopsies in untreated intracranial glial neoplasms.
    Kelly PJ; Daumas-Duport C; Kispert DB; Kall BA; Scheithauer BW; Illig JJ
    J Neurosurg; 1987 Jun; 66(6):865-74. PubMed ID: 3033172
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Intra-arterial chemotherapy with ACNU in the treatment of malignant gliomas].
    Fujiwara T; Matsumoto Y; Tsuchida T; Honma Y; Mino S; Nagao S
    Gan To Kagaku Ryoho; 1992 Apr; 19(4):489-95. PubMed ID: 1313668
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Regrowth patterns of supratentorial gliomas: estimation from computed tomographic scans.
    Tsuboi K; Yoshii Y; Nakagawa K; Maki Y
    Neurosurgery; 1986 Dec; 19(6):946-51. PubMed ID: 3027609
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The prognostic importance of tumor size in malignant gliomas: a computed tomographic scan study by the Brain Tumor Cooperative Group.
    Wood JR; Green SB; Shapiro WR
    J Clin Oncol; 1988 Feb; 6(2):338-43. PubMed ID: 3339397
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intraarterial infusion of carboplatin in the treatment of malignant gliomas: a phase II study.
    Follézou JY; Fauchon F; Chiras J
    Neoplasma; 1989; 36(3):349-52. PubMed ID: 2544815
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Permanent iodine-125 implants in the up-front treatment of malignant gliomas.
    Fernandez PM; Zamorano L; Yakar D; Gaspar L; Warmelink C
    Neurosurgery; 1995 Mar; 36(3):467-73. PubMed ID: 7753345
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Iodine125 labeled anti-epidermal growth factor receptor-425 in the treatment of malignant astrocytomas. A pilot study.
    Brady LW; Markoe AM; Woo DV; Rackover MA; Koprowski H; Steplewski Z; Peyster RG
    J Neurosurg Sci; 1990; 34(3-4):243-9. PubMed ID: 1965903
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intra-arterial bromodeoxyuridine radiosensitization and radiation in treatment of malignant astrocytomas.
    Greenberg HS; Chandler WF; Diaz RF; Ensminger WD; Junck L; Page MA; Gebarski SS; McKeever P; Hood TW; Stetson PL
    J Neurosurg; 1988 Oct; 69(4):500-5. PubMed ID: 3047341
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Value of sequential computed tomography in the multimodality treatment of glioblastoma multiforme.
    Salcman M; Levine H; Rao K
    Neurosurgery; 1981 Jan; 8(1):15-9. PubMed ID: 6259550
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diagnostic and therapeutic impact of computerized tomography in patients with malignant brain tumours: South Australian experience.
    Sage MR; Wilson BC; Benness GT
    Med J Aust; 1980 Nov; 2(9):493-6. PubMed ID: 6259501
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Follow-up study of malignant astrocytomas showing complete response after initial treatment].
    Kumabe T; Kayama T; Yoshimoto T; Mizoi K
    No Shinkei Geka; 1994 Jun; 22(6):545-51. PubMed ID: 8015675
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Necrosis as a prognostic criterion in malignant supratentorial, astrocytic gliomas.
    Nelson JS; Tsukada Y; Schoenfeld D; Fulling K; Lamarche J; Peress N
    Cancer; 1983 Aug; 52(3):550-4. PubMed ID: 6305479
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Objective antitumor activity of acivicin in patients with recurrent CNS malignancies: a Southwest Oncology Group trial.
    Taylor SA; Crowley J; Pollock TW; Eyre HJ; Jaeckle C; Hynes HE; Stephens RL
    J Clin Oncol; 1991 Aug; 9(8):1476-9. PubMed ID: 1649269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.